NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/29/2024
Back to search
Official data from USPTO
HELIOS BIOSCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
04/29/2024
Trademark type
Combined
Nice classes
5
Filing date
01/22/2014
Registration date
07/10/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/29/2024
Last transaction
04/29/2024
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2013-06-00
First use in commerce
2013-06-00
Drawing code
3
Owner type
03
Owner location
Taipei, TW
Examiner
KENEALY, NATALIE LANGFORD
Law office
L40
Current location
TMEG LAW OFFICE 104
Mark description
The mark consists of the stylized wording "HELIOS" above the wording "BioScience" with a design of some connected circles in the letter "O" of "HELIOS".
Holders and representatives
Holders
AVENTACELL BIOMEDICAL CO., LTD.
GWOWEI TECHNOLOGY CO., LTD.
Representatives
Michael T. Smith Birch Stewart Kolasch & Birch, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicated serums for treatment of skinhaireyestissuefor use in dermatologyophthalmology and orthopedics; Medicinal hair growth preparations; Medicated hair tonic agents for preventing hair loss; Medicines for human usepharmaceutical preparations for the treatment of damaged skin and tissueinflammatory system disorderstendon and muscle injuriescartilage and bone injuries and regenerationfor use in dermatologyophthalmology and orthopedics; Medicinal agents for human usepharmaceutical preparations for the treatment of damaged skin and tissueinflammatory system disorderstendon and muscle injuriescartilage and bone injuries and regenerationfor use in dermatology; Preparations to facilitate teething; Pharmaceutical preparations for skin care; Blood plasma; Albuminous preparations for medical use; Wadding for medical use; Culture mediacell culture supplements for medical use for cultivating human cells
Publications
History of USPTO decisions and trademark events.
48 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
04/29/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/22/2024
PUM1
OFFICE ACTION ISSUED POU1
10/26/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/25/2023
ES8R
TEAS SECTION 8 RECEIVED
10/06/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/10/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/10/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/06/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/05/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/16/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/16/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/15/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/15/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/14/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/09/2018
IUAF
USE AMENDMENT FILED
04/19/2018
EISU
TEAS STATEMENT OF USE RECEIVED
04/19/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/07/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/12/2017
PUBO
PUBLISHED FOR OPPOSITION
09/12/2017
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/23/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/23/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/04/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
08/04/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/04/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
08/04/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/04/2017
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/13/2017
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/12/2017
ALIE
ASSIGNED TO LIE
01/10/2017
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/01/2016
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/18/2015
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/13/2015
ALIE
ASSIGNED TO LIE
05/06/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/30/2014
GNSL
LETTER OF SUSPENSION E-MAILED
10/30/2014
CNSL
SUSPENSION LETTER WRITTEN
10/30/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/23/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/04/2014
GNRT
NON-FINAL ACTION E-MAILED
05/04/2014
CNRT
NON-FINAL ACTION WRITTEN
05/04/2014
DOCK
ASSIGNED TO EXAMINER
04/25/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/04/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2014
NWAP
NEW APPLICATION ENTERED
01/25/2014
Continuous trademark protection
Get notified about every new filing that threatens HELIOS BIOSCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.